Avenue Therapeutics, Inc. (ATXI)
OTCMKTS
· Delayed Price · Currency is USD
0.7690
-0.0310 (-3.88%)
At close: Dec 5, 2025
Avenue Therapeutics Market Cap
Avenue Therapeutics has a market cap or net worth of $2.45 million as of December 5, 2025. Its market cap has decreased by -23.64% in one year.
Market Cap
2.45M
Enterprise Value
-2.51M
Revenue
1.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.77
Market Cap Chart
Since June 27, 2017, Avenue Therapeutics's market cap has decreased from 27.57M to 2.45M, a decrease of -91.12%. That is a compound annual growth rate of -24.92%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 569.32M |
| Glass House Brands | 503.27M |
| CytoDyn | 416.55M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 359.36M |
| Silence Therapeutics | 295.21M |
| Nika Pharmaceuticals | 259.91M |